Related Experiment Video
Updated: May 24, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Clinical implications of molecular changes in pediatric Barrett's esophagus
Licia Pensabene1, Marta C Cohen, Michael Thomson
1Department of Paediatrics, Pugliese-Ciaccio Hospital, University "Magna Græcia" of Catanzaro, Catanzaro, Italy, pensabene@unicz.it
Insights
Barrett's esophagus (BE), a preneoplastic condition, may be increasing in children. Identifying new biomarkers is crucial for managing BE and preventing esophageal adenocarcinoma.
Area of Science:
- Gastroenterology and Oncology
Background:
- Barrett's esophagus (BE) is a preneoplastic condition linked to esophageal adenocarcinoma.
- Limited data exist on pediatric BE, but recent studies suggest an increasing incidence.
- BE development involves genetic predisposition interacting with environmental factors, leading to molecular changes.
Purpose of the Study:
- To highlight the need for objective risk markers in Barrett's esophagus management.
- To explore the potential of molecular genetics in paraffin-embedded biopsies for understanding BE.
- To identify biomarkers for improved treatment strategies in BE patients.
Main Methods:
- Review of current understanding of BE pathogenesis and progression.
- Discussion of the limitations of endoscopic surveillance biopsies.
- Emphasis on molecular genetic analysis of existing biopsy samples.
Main Results:
- BE is a complex disease with genetic and environmental influences.
- Early premalignant clones exhibit heterogeneity, driving disease progression.
- Current surveillance methods have limitations due to sampling errors.
Conclusions:
- Objective, less error-prone risk markers are needed for BE management.
- Molecular genetics on paraffin-embedded biopsies can enhance understanding of BE.
- Biomarkers derived from molecular analysis may guide BE treatment strategies.
Abstract:
Barrett's esophagus (BE) is a preneoplastic condition that predisposes to esophageal adenocarcinoma. Although data on the occurrence of BE in children are limited, recent studies have suggested an increase in the pediatric population. BE is thought to be a complex disease in which individual genetic predisposition interacts with environmental stimuli. Early premalignant clones produce biological and genetic heterogeneity, resulting in stepwise changes in differentiation, proliferation, and apoptosis, allowing disease progression under selective pressure. The value of endoscopic surveillance biopsy for dysplasia and carcinoma in patients with BE is controversial. Thus, the recognition of early and objective alternative risk markers, less susceptible of sampling error, will be of relevance in the management of BE patients. The possibility of performing molecular genetics on paraffin-embedded biopsies will expand our understanding of the natural history of BE and may lead to the use of biomarkers to inform treatment strategies.
Related Concept Videos
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Cellular Adaptation IV: Dysplasia and Metaplasia
Gastroesophageal Reflux Disease

